ÂÜÀòÂÒÂ×

Michaela Pallua's work experience includes a variety of roles in the pharmaceutical industry. Michaela is currently working as the Country Medical Lead at Stemline Therapeutics since December 2022. Prior to that, they held the position of Head Medical Affairs Hematology at The Janssen Pharmaceutical Companies of Johnson & Johnson starting from June 2020. From August 2016 to June 2020, they worked as the Head Medical Affairs Immunology at AbbVie. Michaela also has experience as a BioT Value Lead at Abbvie GbmH from August 2015 to April 2017.

Before joining AbbVie, Michaela held several positions at Novartis. From March 2013 to July 2015, they worked as a Market Access Manager Oncology at Novartis Pharma Schweiz AG. Prior to that, they served as the Head Scientific Operations at Novartis Oncology from June 2012 to March 2013.

Earlier in their career, Michaela worked at Genzyme Europe B.V. where they held the roles of Country Medical Manager Austria from January 2009 to May 2012 and Project Manager Oncology from April 2008 to January 2009. Michaela also worked as a Project Manager for Lysosomal storage disorders at Genzyme Europe B.V. from September 2005 to March 2007.

Michaela's early experience includes positions at AstraZeneca and Astrazenca. Michaela worked as a Brand Manager Oncology at AstraZeneca from January 2001 to August 2005. Prior to that, they served as a Medical Officer Oncology at Astrazenca from November 1999 to January 2001.

Michaela Pallua attended the Medical University of Vienna, although the specific years of attendance, degree obtained, and field of study are not provided.